Rutgers University at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Rutgers University brings 3 presentations to ASH 2026 in New Orleans. Its program centres on fibrinolysis and resistance to blood cancer therapy. Sessions cover regulators of clot breakdown and therapy resistance mechanisms, plus palliative care in septic shock.
| Organization | ASH 2026 Attendance |
|---|---|
Rutgers University New Brunswick, NJ | |
New Jersey's state research university, with main campuses in New Brunswick and Piscataway. | Session Fri Dec 11 3:00pm–6:00pm Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies Why blood cancers resist therapy, and how to anticipate or reverse that resistance as targeted drugs multiply. Session Fri Dec 11 5:00pm–5:55pm Targeting Protein-Level Vulnerabilities and the Inflammatory Niche in Therapy Resistance Protein-degrading drugs and molecular glues, alongside inflammatory signals in the bone marrow niche, as routes around therapy resistance. Poster Sat Dec 12 5:30pm–7:30pm Talk Sun Dec 13 4:30pm–5:45pm Novel Regulators of Fibrinolysis How fibrin network structure, fiber packing, and mechanical tension decide how easily clots dissolve, and using clot mechanics as disease biomarkers. Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Rutgers University
Tell us what you sell and we’ll find the people at Rutgers University most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction